I am excited to share the results of our recent randomized placebo, controlled, double blind control trial. We tested if high dose famotidine (80mg) TID started within 7 days of symptom onset could help patients with mild to moderate COVID-19. https://t.co/Bvy9deOD16
The section of Genetic Medicine at the University of Chicago is looking for a Scientific Writer. This can be a remote position. If interested, please email me. RTs will be appreciated.
I am excited to share the results of our recent randomized placebo, controlled, double blind control trial. We tested if high dose famotidine (80mg) TID started within 7 days of symptom onset could help patients with mild to moderate COVID-19. https://t.co/Bvy9deOD16
#hiring - Anyone interested in growing human pancreatic cancer organoids and advancing therapeutics? I am looking for excited research technicians to join #TuvesonLab@CSHL in our quest to cure cancer!
#jobsearch#researchjobs
https://t.co/apEnQ0MA8h
Healthcare professionals I need your help to get this new @PancreaticCanUK graphic out in the healthcare system please read understand and most importantly share with as many people as possible #sethslegacy
The NCI now funds about 1 in every 8 qualified proposals, which leaves promising areas of research unexplored—and promising investigators unsupported. Increasing the NCI payline will sustain and diversify the pipeline of cancer scientists and accelerate progress against cancer.
Great discussion and webinar. Thank you as well for the invitation but more important thank you @lustgartenfdn for your incredible support. This work would not be where it is without you! 🥼 🧫 🧪